UNCY

Unicycive Therapeutics, Inc.

Healthcare · Biotechnology

$218.84 sample

+0.75 (+0.34%) 1D

Market cap

$751.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-08

Alerts

8

Price$218.84 -3.62% 3M daily closessample

235.05210.64

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider buy: Chief Financial Officer
Oct 01INSInsider buy: EVP, Operations
Sep 28INSInsider buy: 10% owner
Sep 17INSInsider sell: EVP, Operations
Sep 11INSInsider buy: Director
Sep 08SECDEF 14A filed
Sep 01SEC8-K filed: material event
Aug 27INSInsider sell: Chief Financial Officer

Sign up to see the real UNCY record →

Company facts

SEC EDGAR registration

Name: Unicycive Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +29sample, -100 to +100
Reporting currency: USD

Who is positioning in UNCY

sample

Insiders: 25 insider transactions over 90 days, net selling, $271.7M
Congress: 2 members traded over 90 days
Institutions · 13F: 22 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$32.8B +15.8% y/y

Q4 2024Q3 2026

Inventory$19.7B +22.0% y/y

Q4 2024Q3 2026

Accounts receivable$14.3B +14.8% y/y

Q4 2024Q3 2026

Total debt$38.3B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $584.0B +0.1% 3M
Sample peer B: $434.8B +12.9% 3M
Sample peer C: $216.1B +7.9% 3M
Sample peer D: $599.4B +4.7% 3M
Sample peer E: $441.8B +5.1% 3M